secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2023-12-14T23:59:59+00:00
Accession:  0001140361-23-057648
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics issues $1.5M promissory note to Charles Cherington due Jan 8, 2024 at 6%
--------------------------------------------------------------------------------

- Principal amount $1,500,000; interest rate 6% per annum; matures January 8, 2024.
- Promissory Note is a senior unsecured obligation; ranks equally with existing unsubordinated debt.
- Proceeds received on December 8, 2023; use of proceeds not specified beyond general corporate purposes.
- Customary events of default include payment failure, bankruptcy, material adverse effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000114036123057648/0001140361-23-057648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000114036123057648/ef20016590_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-057648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer